Create an Account

Register to access your existing Transamerica accounts.

View login

Transamerica Multi-Cap Growth*** - Documents

Quarterly fact sheet

Class A ITSAX | Class C ITSLX | Class I TGPIX | Advisor Class TAMHX | Class T1 TGPTX
Back to Funds

DATA AS OF 01/31/2018


*Expense ratios are as-of the most recent prospectus. Contractual arrangements have been made with the fund’s investment manager, Transamerica Asset Management, Inc. (“TAM”), through March 1, 2018.
**Reflects average annual returns. Returns for funds that are less than one year old are not annualized.
***Formerly known as Transamerica Growth Opportunities. 

Prior to March 22, 2011, the fund had a different sub-advisor, a different investment objective, and used different investment strategies to a previous sub-advisor.
Prior to March 1, 2016, the fund had a different sub-advisor, a different investment objective, used different investment strategies and had a different benchmark index.

The performance data presented here represents past performance; Past performance is not indicative of future results. Current performance may be lower or higher than the performance data quoted. The investment return and principal value will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. Performance may not be available for all periods indicated. Net Asset Value (NAV) returns include reinvestment of dividends and capital gains, but do not reflect any sales charges. If a sales charge had been deducted, the results would have been lower. Public Offering Price (POP) returns include reinvestment of dividends and capital gains, and reflect the maximum sales charge.

Maximum sales charge for Class A shares is 5.50%.

Maximum applicable contingent deferred sales charges for Class B is 5.00% in the first year, decreasing to 0% after five years.

Purchases of Class C Shares are subject to a 1.00% contingent deferred sales charge if redeemed during the first 12 months of purchase.

There are no sales charges on Class I shares. Class I shares are currently primarily offered for investment to institutional investors including, but not limited to, fee-based programs, pension plans, and certain endowment plans and foundations.

There are no sales charges on Class I2 shares. Class I2 shares are currently primarily offered for investment by certain funds of funds.

Advisor Class shares are intended for purchase through self-directed accounts on transaction-based platforms that may or may not charge a transaction fee, broker-dealer sponsored fee-based wrap programs, fee-based advisory platforms and bank/trust products where fees are being charged.

Performance figures reflect any fee waivers and/or expense reimbursements by the Investment Manager. Without such waivers and/or reimbursements, the performance would be lower. Future waivers and/or reimbursements are at the discretion of the Investment Manager.

1 Year returns reflect total return.


Standard Deviation is a statistical measurement that helps to gauge the fund's historical volatility. Historical Beta illustrates a fund's sensitivity to price movements in relation to a benchmark index. Alpha is a coefficient measuring the portion of a fund's return arising from specific (non-market) risk. Tracking Error is the difference between the price behavior of a fund and the price behavior of a benchmark. R-Squared is a statistical measure that represents the percentage of a fund's movements that can be explained by movements in a benchmark index. Sharpe Ratio is a risk-adjusted measure calculated by using standard deviation and excess return to determine reward per unit of risk. Information Ratio is a ratio of portfolio returns above those of a benchmark compared to the volatility of those returns.

U.S. allocations may include U.S. territories and possessions.

The Net Other Assets (Liabilities) category may include, but is not limited to, repurchase agreements, reverse repurchase agreements, security lending collateral, forward foreign currency contracts, and cash collateral.